Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes.

Maria Teresa Voso, Gina Zini Tanzi, Emiliano Fabiani, Giuseppe Leone

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

93 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes.'. Insieme formano una fingerprint unica.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science